Chemical industry – Page 15
-
BusinessChemours sacks top executives following accounting probe
Review found officers manipulated cashflow to hit targets and affect bonus payments
-
FeatureIndustry’s water sustainability crisis
As the chemical industry decarbonises, will it require more water? Angeli Mehta looks at whether there is enough to go round
-
OpinionWater isn’t normal
Despite its familiarity, water is a chemical oddity. But that’s what makes it fascinating
-
-
BusinessUS government moves to block Chinese biotechs’ operations
WuXi Apptec and others accused of national security risk, as trade groups back legislation limiting their activities
-
BusinessUS derailment highlights continuing chemical rail freight concerns
Three-train crash in Pennsylvania leaked diesel and plastic pellets into waterways
-
BusinessChemours suspends chief and senior executives over accounting issues
Auditors to investigate issues around whistleblowing and financial management
-
OpinionFrom one sinking ship to another?
Biogen abandoning Alzheimer’s antibody aducanumab is unusual, but hardly surprising, says Derek Lowe
-
NewsEPA’s updated chemical risk management plans rile industry groups
12,000 chemical plants required to draw up emergency plans for extreme weather and share hazard information with local communities
-
BusinessSustainability – from dirty word to industry imperative
Efforts to reduce the environmental impact of chemical processes have shaped the evolution of the entire sector
-
OpinionMaking chemicals safe and sustainable
The green transition is an opportunity to also make industry simpler and safer
-
BusinessUN human rights experts condemn DuPont and Chemours
PFAS discharges from US plant denied community access to safe water, UN advisors assert
-
BusinessBig deals confirm renewed interest in radiopharmaceuticals
Acquisitions of RayzeBio and Point Biopharma highlight the potential of targeting radioactivity directly to tumour cells
-
BusinessUS federal court revokes approval of dicamba herbicides
Judge overturns 2020 reapproval of three products over procedural failure
-
BusinessNovo Holdings to buy contract manufacturer Catalent for $16.5 billion
Parent firm will then sell on three manufacturing sites to Novo Nordisk to boost capacity for diabetes and weight loss drugs
-
BusinessUS industry leaders repeat calls to reinstate security programme
Six month gap in vetting people with access to high-risk chemicals means potential threats may have been missed
-
BusinessEU renewal of glyphosate approval formally challenged
Environmental coalition says independent data was not considered in decision
-
OpinionHarnessing fear and greed for innovation
Many powerful emotions motivate us in the search for new knowledge
-
BusinessNew Covid-19 antiviral cuts symptoms by 1.5 days
Simnotrelvir already has emergency approval in China
-
BusinessRed Sea shipping attacks are impacting the chemical industry
Route diversions around Africa mean longer transport times and higher prices